XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer.

Autor: Huang, Ming-Yii1,2,3 (AUTHOR), Huang, Yi-Jung4,5 (AUTHOR), Cheng, Tian-Lu5,6 (AUTHOR), Jhang, Wun-Ya7 (AUTHOR), Ke, Chien-Chih5,8,9 (AUTHOR), Chen, Yi-Ting10,11 (AUTHOR), Kuo, Shih-Hsun1 (AUTHOR), Lin, I-Ling7 (AUTHOR), Huang, Yu-Hsiang12 (AUTHOR), Chuang, Chih-Hung5,7 (AUTHOR) a4132600@gmail.com
Zdroj: Cells (2073-4409). Jun2023, Vol. 12 Issue 11, p1475. 18p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje